drugset / Trial / NCT07242781
A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of Itraconazole and Rifampin on the drug levels of AR-LDD (BMS-986365) in healthy adult male participants.
Timeline
- Start
- 2025-12-15
- Primary completion
- 2026-04-09
- Completion
- 2026-04-21
Outcome
Outcome not reported
Stopped (Business): “Business objectives have changed”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986365 | Other / unclassified | — | — |
| Subject | Itraconazole | Small molecule | — | — |
| Subject | Rifampicin | Small molecule | — | — |
Indications
No indication recorded.